Institute for Glycomics
The Health and Knowledge Precinct boasts some of Australia’s most renowned scientists, research institutes and facilities, including the Institute for Glycomics, Menzies Health Institute and the Gold Coast University Hospital.
Griffith University’s, Institute for Glycomics is the Precinct’s flagship translational biomedical research facility. The Institute was established in 2000 with the vision to become a world leader in the development of next generation drugs and vaccines to fight diseases of global impact.
It was the glycomics approach that led to the discovery of the world’s first anti-influenza drug, Zanamivir (Relenza®) by the Institute’s founding Director, Professor Mark von Itzstein.
“From the laboratory bench to the patient’s bedside, translational outcomes are the ultimate goal of Institute for Glycomics research.”
– Professor Mark von Itzstein, Executive Director, Institute for Glycomics, Griffith University
• Cancer Glycomics
• Clinical Trials
• Computational Biology
• Drug and Vaccine Discovery & Development
• Glycomics Array & Other Enabling Technologies
• Infectious Diseases Research
• Medicinal Chemistry & Carbohydrate Synthesis
• Molecular Biophysics
• Structure-Based Drug Design
“With a strong focus on partnering with biotech and pharma companies internationally we are achieving our vision of bringing forward novel medicines and vaccines to the global community.”
– Dr Chris Davis, General Manager, Institute for Glycomics, Griffith University